http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 849 reviews. 849 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Piptalake P

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Piptalake P uses and description

Sort by popularity
Piptalake P consists of Piperidyl Benzilate, Phenobarbital.

Phenobarbital - Pharmacology: Depresses sensory cortex, decreases motor activity, alters cerebellar function and produces drowsiness, sedation, and hypnosis.

Indication: Short-term treatment of insomnia; long-term treatment of generalized tonic-clonic and cortical focal seizures; emergency control of acute convulsions; preanesthetic sedation.

Unlabeled Uses

Treatment of febrile seizures in children; treatment and prevention of hyperbilirubinemia in newborns; management of chronic cholestasis.

Piptalake P (Phenobarbital) is in a group of drugs called barbiturates (bar-BIT-chur-ates). Piptalake P (Phenobarbital) slows the activity of your brain and nervous system.

Piptalake P (Phenobarbital) is used to treat or prevent seizures. It is also used short-term to treat insomnia, or as a sedative before surgery.

Piptalake P (Phenobarbital) may also be used for purposes not listed in this medication guide.

Piptalake P (Phenobarbital) is an anticonvulsant, hypnotic, sedative drug. This medication is a long-acting barbiturate. It is believed that the effects of phenobarbital, like other barbiturates, due to the ability to increase and / or mimic the inhibitory effect of GABA on synaptic transmission. Sedative-hypnotic effect due to the suppression of sensory cortex, decrease motor activity, changes in the functional state of the brain. Although the mechanism of action is not fully installed, phenobarbital, like other barbiturates apparently is particularly active at the level of the thalamus, which suppresses the rising holding in the reticular formation, thereby preventing transmission of impulses in the cerebral cortex. Anticonvulsant effect is due to suppression of the monosynaptic and polysynaptic transmission in the CNS.

Piptalake P (Phenobarbital) causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) reduces the concentration of serum bilirubin.

Like other barbiturates, this medicine contributes to the induction of microsomal liver enzymes, thereby enhancing or altering the metabolism of other drugs.

Piptalake P (Phenobarbital), the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Oral Partial seizures

Adult: 60-180 mg daily taken at night. Titrate dose according to patient\'s needs to achieve adequate control of seizures. Plasma concentrations of 15-40 mcg/ml (65-170 micromol/l) are usually required.

Child: 1 mth-12 yr: Initially, 1-1.5 mg/kg bid. Increase by 2 mg/kg daily, as required, to a maintenance dose of 2.5-4 mg/kg once or bid. 12-18 yr: Initially, 60-180 mg bid.

Maintenance: 60-180 mg once daily. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Generalised tonic-clonic seizures

Adult: 60-180 mg daily taken at night. Titrate dose according to patient\'s needs to achieve adequate control of seizures. Plasma concentrations of 15-40 mcg/ml (65-170 micromol/l) are usually required.

Child: 1 mth-12 yr: Initially, 1-1.5 mg/kg bid. Increase by 2 mg/kg daily, as required, to a maintenance dose of 2.5-4 mg/kg once or bid. 12-18 yr: Initially, 60-180 mg bid.

Maintenance: 60-180 mg once daily. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Sedation

Adult: 30-120 mg/day in 2-3 divided doses.

Child: 6 mg/kg/day or 180 mg/m 2 /day divided in 3 equal doses. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Hypnotic

Adult: 100-320 mg at bedtime. Do not admin for >2 wk for the treatment of insomnia. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Preoperative sedation

Child: 1-3 mg/kg 1-1.5 hr before procedure. Intramuscular Emergency management of acute seizures

Adult: As sodium: 200 mg IM repeated after 6 hr if necessary.

Child: As sodium: 15 mg/kg IM as a single dose. Intravenous Status epilepticus

Adult: Doses of 10 mg/kg to a max of 1 g.

Child: As sodium: Neonates and children up to 12 yr: Initially, 20 mg/kg by slow IV inj then 2.5-5 mg/kg once or bid. 12-18 yr: Initially 20 mg/kg (max 1 g) by slow IV inj then 300 mg bid. Intravenous Generalised tonic-clonic seizures

Child: As sodium: Neonates: Loading dose is 20 mg/kg by slow IV inj followed by 2.5-5 mg/kg once daily either by slow IV inj or orally. Intravenous Partial seizures

Child: As sodium: Neonates: Loading dose is 20 mg/kg by slow IV inj followed by 2.5-5 mg/kg once daily either by slow IV inj or orally. Intramuscular Sedation

Adult: As sodium: 30-120 mg/day in 2-3 divided doses. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Parenteral Hypnotic

Adult: As sodium: 100-320 mg at bedtime via IM/IV/SC inj.

Child: As sodium: 3-5 mg/kg at bedtime via IM/IV/SC inj. Hepatic impairment: Severe: Monitor plasma levels and adjust dose accordingly. Intramuscular Preoperative sedation

Adult: As sodium: 100-200 mg 1-1.5 hr before procedure.

Child: As sodium: 16-100 mg 1-1.5 hr before procedure. Intravenous Preoperative sedation

Child: As sodium: 1-3 mg/kg 1-1.5 hr before procedure. Reconstitution: Inj should be diluted 1 in 10 although 15 mg/ml may be considered in fluid-restricted children. Give dose over 20 min at a rate no >1 mg/kg/min. Incompatibility: Y-site admin incompatible with amphotericin B cholesteryl sulfate complex, hydromorphone. Do not mix in the same syringe with hydromorphone, pentazocine, ranitidine, sufentanil. Do not admix with chlorpromazine, cimetidine, clindamycin, dimenhydrinate, diphenhydramine, droperidol, ephedrine, hydralazine, hydrocortisone sodium succinate, hydroxyzine, insulin (regular), kanamycin, levorphanol, meperidine, morphine, norepinephrine, pancuronium, penicillin G, pentazocine, phenytoin, procaine, prochlorperazine, promazine, promethazine, streptomycin, succinylcholine, vancomycin.

Oral Partial seizures

Adult: 60-180 mg daily taken at night. Titrate dose according to patient\'s needs to achieve adequate control of seizures. Plasma concentrations of 15-40 mcg/ml (65-170 micromol/l) are usually required.

Child: 1 mth-12 yr: Initially, 1-1.5 mg/kg bid. Increase by 2 mg/kg daily, as required, to a maintenance dose of 2.5-4 mg/kg once or bid. 12-18 yr: Initially, 60-180 mg bid.

Maintenance: 60-180 mg once daily. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Generalised tonic-clonic seizures

Adult: 60-180 mg daily taken at night. Titrate dose according to patient\'s needs to achieve adequate control of seizures. Plasma concentrations of 15-40 mcg/ml (65-170 micromol/l) are usually required.

Child: 1 mth-12 yr: Initially, 1-1.5 mg/kg bid. Increase by 2 mg/kg daily, as required, to a maintenance dose of 2.5-4 mg/kg once or bid. 12-18 yr: Initially, 60-180 mg bid.

Maintenance: 60-180 mg once daily. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Sedation

Adult: 30-120 mg/day in 2-3 divided doses.

Child: 6 mg/kg/day or 180 mg/m 2 /day divided in 3 equal doses. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Hypnotic

Adult: 100-320 mg at bedtime. Do not admin for >2 wk for the treatment of insomnia. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Oral Pre-operative sedation

Child: 1-3 mg/kg 1-1.5 hr before procedure. Intravenous Status epilepticus

Adult: Doses of 10 mg/kg to a max of 1 g.

Child: As sodium: Neonates and children up to 12 yr: Initially, 20 mg/kg by slow IV inj then 2.5-5 mg/kg once or bid. 12-18 yr: Initially 20 mg/kg (max 1 g) by slow IV inj then 300 mg bid. Intravenous Generalised tonic-clonic seizures

Child: As sodium: Neonates: Loading dose is 20 mg/kg by slow IV inj followed by 2.5-5 mg/kg once daily either by slow IV inj or orally. Intravenous Partial seizures

Child: As sodium: Neonates: Loading dose is 20 mg/kg by slow IV inj followed by 2.5-5 mg/kg once daily either by slow IV inj or orally. Intravenous Pre-operative sedation

Child: As sodium: 1-3 mg/kg 1-1.5 hr before procedure. Intramuscular Emergency management of acute seizures

Adult: As sodium: 200 mg IM repeated after 6 hr if necessary.

Child: As sodium: 15 mg/kg IM as a single dose. Intramuscular Sedation

Adult: As sodium: 30-120 mg/day in 2-3 divided doses. CrCl (ml/min) Dosage Recommendation <10 Administer every 12-16 hr. Hepatic impairment: Severe: Monitor plasma levels and adjust dose as necessary. Intramuscular Pre-operative sedation

Adult: As sodium: 100-200 mg 1-1.5 hr before procedure.

Child: As sodium: 16-100 mg 1-1.5 hr before procedure. Parenteral Hypnotic

Adult: As sodium: 100-320 mg at bedtime via IM/IV/SC inj.

Child: As sodium: 3-5 mg/kg at bedtime via IM/IV/SC inj. Hepatic impairment: Severe: Monitor plasma levels and adjust dose accordingly. Reconstitution: Inj should be diluted 1 in 10 although 15 mg/ml may be considered in fluid-restricted children. Give dose over 20 min at a rate no >1 mg/kg/min. Incompatibility: Y-site admin incompatible with amphotericin B cholesteryl sulfate complex, hydromorphone. Do not mix in the same syringe with hydromorphone, pentazocine, ranitidine, sufentanil. Do not admix with chlorpromazine, cimetidine, clindamycin, dimenhydrinate, diphenhydramine, droperidol, ephedrine, hydralazine, hydrocortisone sodium succinate, hydroxyzine, insulin (regular), kanamycin, levorphanol, meperidine, morphine, norepinephrine, pancuronium, penicillin G, pentazocine, phenytoin, procaine, prochlorperazine, promazine, promethazine, streptomycin, succinylcholine, vancomycin.

Piptalake P (Phenobarbital) DC Labs causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Dalkhimpharm causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Hospira causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Valeant Pharmaceuticals causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Pharmstandard-Leksredstva causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Moscow Endocrine Plant causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) Sandoz causes a dose-dependent respiratory depression.

Piptalake P (Phenobarbital) ERFA causes a dose-dependent respiratory depression.

Active ingredients: Piperidyl Benzilate/Phenobarbital
Unit description, dosagePrice, USD

List of piptalake p brand and generic drugs

Piperidyl Benzilate/Phenobarbital
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer